Immunophenotyping in peripheral blood mononuclear cells, aqueous humour and vitreous in a Blau syndrome patient caused by a novel NOD2 mutation

被引:15
|
作者
Jimenez-Martinez, M. C. [1 ,2 ,3 ]
Cruz, F. [4 ]
Groman-Lupa, S. [1 ,2 ]
Zenteno, J. C. [1 ,3 ,5 ]
机构
[1] Inst Ophthalmol Conde de Valenciana, Res Unit, Mexico City 06800, DF, Mexico
[2] Inst Ophthalmol Conde de Valenciana, Dept Immunol, Mexico City 06800, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico
[4] Natl Med Ctr La Raza, IMSS, Mexico City, DF, Mexico
[5] Inst Ophthalmol Conde de Valenciana, Dept Genet, Mexico City 06800, DF, Mexico
关键词
FAMILIAL GRANULOMATOUS ARTHRITIS; EARLY-ONSET SARCOIDOSIS; HOMING T-CELLS; CHEMOKINE RECEPTORS; CARD15; MUTATIONS; ANKYLOSING-SPONDYLITIS; EXPRESSION; LIVER; CCR4; SUSCEPTIBILITY;
D O I
10.1111/j.1744-313X.2011.00998.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
P>The genetic and immunophenotypic characteristics of a 3-year-old patient with Blau syndrome (BS), an early onset sarcoidosis caused by mutations in NOD2, were investigated. Molecular analysis of NOD2 gene was achieved by PCR and direct nucleotide sequencing. Immunophenotyping included cytometric analysis of memory-effector markers on T-cells, and cytokine in serum, aqueous humour and vitreous. A novel M513R mutation in NOD2 was demonstrated. Immunophenotyping revealed higher frequency of CCR4+ cells and CCR9+ cells on CD4+ cells; most CD8+ cells were CCR7- and CCR9+. IL6 and IL-8 were detected in a gradient manner: vitreous humour > aqueous humour > serum. The immunophenotype in this patient was characterized by a differential expression of chemokine receptors on T cells and by a particular ocular microenvironment enriched in IL-6 and IL-8. To our knowledge, this is the first study analysing the immunological features of BS at aqueous humour, vitreous and blood levels. Our results expand the knowledge of the genetic and immunopathological basis of BS.
引用
收藏
页码:233 / 242
页数:10
相关论文
共 50 条
  • [21] Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation
    Matsuda, Tomoko
    Kambe, Naotomo
    Ueki, Yoko
    Kanazawa, Nobuo
    Izawa, Kazushi
    Honda, Yoshitaka
    Kawakami, Atsushi
    Takei, Syuji
    Tonomura, Kyoko
    Inoue, Masami
    Kobayashi, Hiroko
    Okafuji, Ikuo
    Sakurai, Yoshihiko
    Kato, Naoki
    Maruyama, Yuta
    Inoue, Yuzaburo
    Otsubo, Yoshikazu
    Makino, Teruhiko
    Okada, Satoshi
    Kobayashi, Ichiro
    Yashiro, Masato
    Ito, Shusaku
    Fujii, Hiroshi
    Kondo, Yasuhiro
    Okamoto, Nami
    Ito, Shuichi
    Iwata, Naomi
    Kaneko, Utako
    Doi, Mototsugu
    Hosokawa, Junichi
    Ohara, Osamu
    Saito, Megumu K.
    Nishikomori, Ryuta
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (11) : 1492 - 1499
  • [22] Blau Syndrome-Associated Nod2 Mutation Alters Expression of Full-Length NOD2 and Limits Responses to Muramyl Dipeptide in Knock-in Mice
    Dugan, Jae
    Griffiths, Eric
    Snow, Paige
    Rosenzweig, Holly
    Lee, Ellen
    Brown, Brieanna
    Carr, Daniel W.
    Rose, Carlos
    Rosenbaum, James
    Davey, Michael P.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (01): : 349 - 357
  • [23] A Novel NOD2-associated Mutation and Variant Blau Syndrome: Phenotype and Molecular Analysis
    Ebrahimiadib, Nazanin
    Abu Samra, Khawla
    Domina, Aaron M.
    Stiles, Ethan R.
    Ewer, Roger
    Bocian, Charlie P.
    Foster, C. Stephen
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (01) : 57 - 64
  • [24] Increased inflammatory responsiveness of peripheral blood mononuclear cells (PBMCs) to in vitro NOD2 ligand stimulation in patients with ankylosing spondylitis
    Vanaki, Negar
    Golmohammadi, Taghi
    Jamshidi, Ahmadreza
    Akhtari, Maryam
    Vojdanian, Mahdi
    Mostafaei, Shayan
    Poursani, Shiva
    Ahmadzadeh, Nooshin
    Mahmoudi, Mahdi
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2018, 40 (05) : 393 - 400
  • [25] FUNCTIONAL ANALYSIS OF PERIPHERAL BLOOD MONONUCLEAR CELLS IN A FCAS PATIENT WITH NOVEL NLRP3 MUTATION
    Izumikawa, M.
    Dobashi, H.
    Susaki, K.
    Kameda, T.
    Takeuchi, Y.
    Nakashima, S.
    Shimada, H.
    Ozaki, H.
    Matsunaga, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 324 - 325
  • [26] Rare disease or rare diagnosed diseases: Blau syndrome with a rare mutation in exon 9 of NOD2 gene from Canakkale
    Silan, Fatma
    Djurovic, Jelena
    Bir, Firdevs Dincsoy
    Silan, Coskun
    Ozdemir, Ozturk
    JOURNAL OF BIOTECHNOLOGY, 2018, 280 : S65 - S65
  • [27] Functional Expression of NOD2 in Freshly Isolated Human Peripheral Blood γδ T Cells
    Marischen, L.
    Wesch, D.
    Oberg, H. -H.
    Rosenstiel, P.
    Trad, A.
    Shomali, M.
    Groetzinger, J.
    Janssen, O.
    Tchikov, V.
    Schuetze, S.
    Kabelitz, D.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 74 (02) : 126 - 134
  • [28] Nucleotide-binding and oligomerization domain 2 (NOD2) knock-in mice carrying a mutation associated with Blau syndrome show reduced amounts of NOD2 protein and decreased muramyl dipeptide (MDP)-induced inflammatory responses
    Dugan, Jae
    Griffiths, Eric
    Snow, Paige
    Rosenzweig, Holly
    Carr, Daniel
    Rosenbaum, Jim
    Davey, Michael
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [29] Novel Missense Mutation in the NOD2 Gene in a Patient with Early Onset Ulcerative Colitis: Causal or Chance Association?
    Girardelli, Martina
    Vuch, Josef
    Tommasini, Alberto
    Crovella, Sergio
    Bianco, Anna Monica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (03): : 3834 - 3841
  • [30] A sporadic case of early-onset sarcoidosis resembling Blau syndrome due to the recurrent R334W missense mutation on the NOD2 gene
    Coto-Segura, P.
    Mallo-Garcia, S.
    Costa-Romero, M.
    Arostegui, J. I.
    Yague, J.
    Ramos-Polo, E.
    Santos-Juanes, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (06) : 1257 - 1259